Leukemia
The Leukemia & Lymphoma Society and the University of Kansas Cancer Center Announce Innovative Partnership to Accelerate Drug Development
Published in Cancer Weekly, January 20th, 2009
Currently, The University of Kansas Cancer Center (KU Cancer Center) and its partner, Beckloff Associates Inc., are supporting two early stage projects of LLS-funded researchers at The University of Virginia and The University of Toronto. The number of projects is expected to expand over the year.
The University of Kansas is uniquely positioned to work with LLS to accelerate the research it funds. KU Cancer Center has a long history of developing cancer drugs and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-01-20)
More Articles from Cancer Weekly
- AHCC Research Association
Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells - Asthma
American Asthma Foundation Announces Breakthrough Discovery - AuthorHouse
'Life Begins at 65: Words of a Cancer Survivor': New Book Offers Empowering Strategies for Rising Above Sickness and Setbacks - Bladder Cancer
Why Bladder Cancer Is Deadlier for Some - Cancer Gene Therapy
New cancer gene therapy data have been reported by H.J. Wu and co-authors - Cancer Vaccines
Findings from J.M. Tovar and co-authors provide new insights into cancer vaccines - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
